Abstract
BackgroundBuruli ulcer (BU) is a necrotizing skin disease, caused by Mycobacterium ulcerans, with poorly understood acquisition risk factors. This review aims at evaluating the importance of individual–sex, age, family ties with history of BU, gene variants–and clinical–Bacillus Calmette-Guérin (BCG) immunization, Human Immunodeficiency Virus (HIV) infection–variables in this process.MethodsA systematic review was performed considering the following databases: ClinicalTrials.gov, Cochrane Controlled Register of Trials (CENTRAL), Current Contents Connect, Embase, MEDLINE, SciELO, Scopus and Web of Science. Eligible studies were critically appraised with The Joanna Briggs Institute checklists and heterogeneity was assessed with Cochran Q-test and I2 statistic. Published demographic data was descriptively analysed and clinical data pooled within random-effects modelling for meta-analysis.ResultsA total of 29 studies were included in the systematic review. Two randomized controlled trials (RCTs) and 21 case-control studies were selected for meta-analysis. Studies show that BU mainly affects age extremes, more preponderately males among children. Data pooled from RCTs do not reveal BCG to be protective against BU (odds ratio (OR) = 0.63; 95% CI = 0.38–1.05; I2 = 56%), a finding case-control studies appear to corroborate. HIV infection (OR = 6.80; 95% CI = 2.33–19.85; I2 = 0%) and SLC11A1 rs17235409 A allele (OR = 1.86; 95% CI = 1.25–2.77; I2 = 0%) are associated with increased prevalence of the disease. No definite conclusions can be drawn regarding the influence of previous family history of BU.DiscussionWhile available evidence warrants further robustness, these results have direct implications on current interventions and future research programs, and foster the development of more cost-effective preventive and screening measures.RegistrationThe study was registered at PROSPERO with number CRD42019123611.
Highlights
Buruli ulcer (BU) is a neglected tropical chronic skin disease caused by Mycobacterium ulcerans
This review aims at evaluating the importance of individual–sex, age, family ties with history of BU, gene variants–and clinical–Bacillus Calmette-Guerin (BCG) immunization, Human Immunodeficiency Virus (HIV) infection–variables in this process
Two randomized controlled trials (RCTs) and 21 case-control studies were selected for meta-analysis
Summary
Buruli ulcer (BU) is a neglected tropical chronic skin disease caused by Mycobacterium ulcerans. Due to its multiple presentations and the prospect of confounding superinfections, WHO recommends, without compromising the beginning of antibiotherapy, that the diagnosis of BU should include at least one, ideally two, of the following laboratorial methods: a) direct smear examination of acid-fast bacilli (AFB) with Ziehl-Neelsen from a swab or a biopsy; b) histopathology; c) culture on Lowenstein-Jensen medium at 32oC; and d) Polymerase Chain Reaction (PCR) targeting the IS2404 insertion sequence [2] The latter is currently considered the gold standard test, mostly due to its higher sensitivity and specificity (>90%), despite not being available in all laboratories [2]. Buruli ulcer (BU) is a necrotizing skin disease, caused by Mycobacterium ulcerans, with poorly understood acquisition risk factors. This review aims at evaluating the importance of individual–sex, age, family ties with history of BU, gene variants–and clinical–Bacillus Calmette-Guerin (BCG) immunization, Human Immunodeficiency Virus (HIV) infection–variables in this process.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
